Search Orphan Drug Designations and Approvals
-
Generic Name: | nitric oxide |
---|---|
Date Designated: | 09/05/2008 |
Orphan Designation: | Use in combination with a drug delivery device for acute treatment of sickle cell vaso-occlusive crisis (pain crises) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Mallinckrodt Pharmaceuticals Ireland Ltd. College Business & Technology Park Cruiserath Road Blanchardstown, Dublin D15 TX2V Ireland The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-